---
$id: https://graph.org.ai/products/commodity/51131727
$type: Product
source: UNSPSC
code: "51131727"
title: "Ifetroban"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ifetroban

**UNSPSC Code**: 51131727
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C25H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E833KT807K, chemically known as benzenepropanoic acid, 2-((3-(4-((pentylamino)carbonyl)-2-oxazolyl)-7-oxabicyclo(2.2.1)hept-2-yl)methyl)-, (1s-(exo,exo))- but generally known as ifetroban, which bears US NIH Compound Identifier 64924. European Medicines Agency schedules Ifetroban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08124MIG. The term IFETROBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). IFETROBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ifetroban under HS 29349990 and SITC 51579. As of Q4 2014, IFETROBAN remains the US FDA Preferred Term for this commodity. Ifetroban bears US NLM identifiers UMLS ID C0287939 and NCI Concept Code C81570. SMILES: O1C2C(C(C1CC2)C1OCC(N1)C(=O)NCCCCC)CC1C(CCC(=O)O)CCCC1.

